Industry Research Reports
Global Tacrolimus Market Research Report 2026
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Tacrolimus market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Tacrolimus competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Tacrolimus is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Tacrolimus is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Tacrolimus include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group, Takeda, Huapont Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Tacrolimus market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Tacrolimus. The Tacrolimus market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Tacrolimus market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Tacrolimus manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
- GSK
- Abbott
- Roche Pharma
- Novartis
- Mylan
- Squibb
- Astellas
- Aarti Group
- Takeda
- Huapont Pharma
- Senju Pharmaceutical
- Guike Pharmaceutical
- Tecoland
- Sandoz
- ScinoPharm
- RPG Life Science
- Suzhou Pharmaceutical Technology
- Accura Pharmaceuticals
- Fujisawa Pharmaceutical
- Sichuan Med-Shine Pharmaceutical
- Sinopharm Chuankang Pharmaceutical
- Yamanouchi Pharmaceutical
- Zhongmei Huadong Pharmaceutical
- Hisun Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Tacrolimus Capsules
- Tacrolimus Ointment
- Tacrolimus Injection
Segment by Application
- Hospitals
- Clinics
- Other
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Tacrolimus manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Tacrolimus sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Tacrolimus Market Overview
1.1 Product Definition
1.2 Tacrolimus by Type
1.2.1 Global Tacrolimus Market Value by Type: 2025 vs 2032
1.2.2 Tacrolimus Capsules
1.2.3 Tacrolimus Ointment
1.2.4 Tacrolimus Injection
1.3 Tacrolimus by Application
1.3.1 Global Tacrolimus Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Tacrolimus Market Size Estimates and Forecasts
1.4.1 Global Tacrolimus Revenue 2021–2032
1.4.2 Global Tacrolimus Sales 2021–2032
1.4.3 Global Tacrolimus Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Tacrolimus Market Competition by Manufacturers
2.1 Global Tacrolimus Sales Market Share by Manufacturers (2021–2026)
2.2 Global Tacrolimus Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Tacrolimus Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Tacrolimus, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Tacrolimus, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Tacrolimus, Product Types and Applications
2.7 Global Key Manufacturers of Tacrolimus, Date of Entry into the Industry
2.8 Global Tacrolimus Market Competitive Situation and Trends
2.8.1 Global Tacrolimus Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Tacrolimus Players Market Share by Revenue
2.8.3 Global Tacrolimus Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tacrolimus Market Scenario by Region
3.1 Global Tacrolimus Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Tacrolimus Sales by Region: 2021–2032
3.2.1 Global Tacrolimus Sales by Region: 2021–2026
3.2.2 Global Tacrolimus Sales by Region: 2027–2032
3.3 Global Tacrolimus Revenue by Region: 2021–2032
3.3.1 Global Tacrolimus Revenue by Region: 2021–2026
3.3.2 Global Tacrolimus Revenue by Region: 2027–2032
3.4 North America Tacrolimus Market Facts & Figures by Country
3.4.1 North America Tacrolimus Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Tacrolimus Sales by Country (2021–2032)
3.4.3 North America Tacrolimus Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tacrolimus Market Facts & Figures by Country
3.5.1 Europe Tacrolimus Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Tacrolimus Sales by Country (2021–2032)
3.5.3 Europe Tacrolimus Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tacrolimus Market Facts & Figures by Region
3.6.1 Asia Pacific Tacrolimus Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Tacrolimus Sales by Region (2021–2032)
3.6.3 Asia Pacific Tacrolimus Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tacrolimus Market Facts & Figures by Country
3.7.1 Latin America Tacrolimus Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Tacrolimus Sales by Country (2021–2032)
3.7.3 Latin America Tacrolimus Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tacrolimus Market Facts & Figures by Country
3.8.1 Middle East and Africa Tacrolimus Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Tacrolimus Sales by Country (2021–2032)
3.8.3 Middle East and Africa Tacrolimus Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tacrolimus Sales by Type (2021–2032)
4.1.1 Global Tacrolimus Sales by Type (2021–2026)
4.1.2 Global Tacrolimus Sales by Type (2027–2032)
4.1.3 Global Tacrolimus Sales Market Share by Type (2021–2032)
4.2 Global Tacrolimus Revenue by Type (2021–2032)
4.2.1 Global Tacrolimus Revenue by Type (2021–2026)
4.2.2 Global Tacrolimus Revenue by Type (2027–2032)
4.2.3 Global Tacrolimus Revenue Market Share by Type (2021–2032)
4.3 Global Tacrolimus Price by Type (2021–2032)
5 Segment by Application
5.1 Global Tacrolimus Sales by Application (2021–2032)
5.1.1 Global Tacrolimus Sales by Application (2021–2026)
5.1.2 Global Tacrolimus Sales by Application (2027–2032)
5.1.3 Global Tacrolimus Sales Market Share by Application (2021–2032)
5.2 Global Tacrolimus Revenue by Application (2021–2032)
5.2.1 Global Tacrolimus Revenue by Application (2021–2026)
5.2.2 Global Tacrolimus Revenue by Application (2027–2032)
5.2.3 Global Tacrolimus Revenue Market Share by Application (2021–2032)
5.3 Global Tacrolimus Price by Application (2021–2032)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 GSK Tacrolimus Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Tacrolimus Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Roche Pharma
6.3.1 Roche Pharma Company Information
6.3.2 Roche Pharma Description and Business Overview
6.3.3 Roche Pharma Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Roche Pharma Tacrolimus Product Portfolio
6.3.5 Roche Pharma Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novartis Tacrolimus Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Company Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mylan Tacrolimus Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Squibb
6.6.1 Squibb Company Information
6.6.2 Squibb Description and Business Overview
6.6.3 Squibb Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Squibb Tacrolimus Product Portfolio
6.6.5 Squibb Recent Developments/Updates
6.7 Astellas
6.7.1 Astellas Company Information
6.7.2 Astellas Description and Business Overview
6.7.3 Astellas Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Astellas Tacrolimus Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Aarti Group
6.8.1 Aarti Group Company Information
6.8.2 Aarti Group Description and Business Overview
6.8.3 Aarti Group Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Aarti Group Tacrolimus Product Portfolio
6.8.5 Aarti Group Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Company Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Takeda Tacrolimus Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Huapont Pharma
6.10.1 Huapont Pharma Company Information
6.10.2 Huapont Pharma Description and Business Overview
6.10.3 Huapont Pharma Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Huapont Pharma Tacrolimus Product Portfolio
6.10.5 Huapont Pharma Recent Developments/Updates
6.11 Senju Pharmaceutical
6.11.1 Senju Pharmaceutical Company Information
6.11.2 Senju Pharmaceutical Description and Business Overview
6.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Senju Pharmaceutical Tacrolimus Product Portfolio
6.11.5 Senju Pharmaceutical Recent Developments/Updates
6.12 Guike Pharmaceutical
6.12.1 Guike Pharmaceutical Company Information
6.12.2 Guike Pharmaceutical Description and Business Overview
6.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Guike Pharmaceutical Tacrolimus Product Portfolio
6.12.5 Guike Pharmaceutical Recent Developments/Updates
6.13 Tecoland
6.13.1 Tecoland Company Information
6.13.2 Tecoland Description and Business Overview
6.13.3 Tecoland Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Tecoland Tacrolimus Product Portfolio
6.13.5 Tecoland Recent Developments/Updates
6.14 Sandoz
6.14.1 Sandoz Company Information
6.14.2 Sandoz Description and Business Overview
6.14.3 Sandoz Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sandoz Tacrolimus Product Portfolio
6.14.5 Sandoz Recent Developments/Updates
6.15 ScinoPharm
6.15.1 ScinoPharm Company Information
6.15.2 ScinoPharm Description and Business Overview
6.15.3 ScinoPharm Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 ScinoPharm Tacrolimus Product Portfolio
6.15.5 ScinoPharm Recent Developments/Updates
6.16 RPG Life Science
6.16.1 RPG Life Science Company Information
6.16.2 RPG Life Science Description and Business Overview
6.16.3 RPG Life Science Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 RPG Life Science Tacrolimus Product Portfolio
6.16.5 RPG Life Science Recent Developments/Updates
6.17 Suzhou Pharmaceutical Technology
6.17.1 Suzhou Pharmaceutical Technology Company Information
6.17.2 Suzhou Pharmaceutical Technology Description and Business Overview
6.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Portfolio
6.17.5 Suzhou Pharmaceutical Technology Recent Developments/Updates
6.18 Accura Pharmaceuticals
6.18.1 Accura Pharmaceuticals Company Information
6.18.2 Accura Pharmaceuticals Description and Business Overview
6.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Accura Pharmaceuticals Tacrolimus Product Portfolio
6.18.5 Accura Pharmaceuticals Recent Developments/Updates
6.19 Fujisawa Pharmaceutical
6.19.1 Fujisawa Pharmaceutical Company Information
6.19.2 Fujisawa Pharmaceutical Description and Business Overview
6.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Fujisawa Pharmaceutical Tacrolimus Product Portfolio
6.19.5 Fujisawa Pharmaceutical Recent Developments/Updates
6.20 Sichuan Med-Shine Pharmaceutical
6.20.1 Sichuan Med-Shine Pharmaceutical Company Information
6.20.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Portfolio
6.20.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.21 Sinopharm Chuankang Pharmaceutical
6.21.1 Sinopharm Chuankang Pharmaceutical Company Information
6.21.2 Sinopharm Chuankang Pharmaceutical Description and Business Overview
6.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Portfolio
6.21.5 Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
6.22 Yamanouchi Pharmaceutical
6.22.1 Yamanouchi Pharmaceutical Company Information
6.22.2 Yamanouchi Pharmaceutical Description and Business Overview
6.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Portfolio
6.22.5 Yamanouchi Pharmaceutical Recent Developments/Updates
6.23 Zhongmei Huadong Pharmaceutical
6.23.1 Zhongmei Huadong Pharmaceutical Company Information
6.23.2 Zhongmei Huadong Pharmaceutical Description and Business Overview
6.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Portfolio
6.23.5 Zhongmei Huadong Pharmaceutical Recent Developments/Updates
6.24 Hisun Pharmaceutical
6.24.1 Hisun Pharmaceutical Company Information
6.24.2 Hisun Pharmaceutical Description and Business Overview
6.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Hisun Pharmaceutical Tacrolimus Product Portfolio
6.24.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tacrolimus Industry Chain Analysis
7.2 Tacrolimus Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tacrolimus Production Mode & Process Analysis
7.4 Tacrolimus Sales and Marketing
7.4.1 Tacrolimus Sales Channels
7.4.2 Tacrolimus Distributors
7.5 Tacrolimus Customer Analysis
8 Tacrolimus Market Dynamics
8.1 Tacrolimus Industry Trends
8.2 Tacrolimus Market Drivers
8.3 Tacrolimus Market Challenges
8.4 Tacrolimus Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
Table 1. Global Tacrolimus Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Tacrolimus Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Tacrolimus Market Competitive Situation by Manufacturers in 2025
Table 4. Global Tacrolimus Sales (K MT) of Key Manufacturers (2021–2026)
Table 5. Global Tacrolimus Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Tacrolimus Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Tacrolimus Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Tacrolimus Average Price (USD/MT) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Tacrolimus, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Tacrolimus, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Tacrolimus, Product Types and Applications
Table 12. Global Key Manufacturers of Tacrolimus, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tacrolimus Companies by Tier (Tier 1, Tier 2, Tier 3), based on Tacrolimus Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tacrolimus Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Tacrolimus Sales by Region (K MT), 2021–2026
Table 18. Global Tacrolimus Sales Market Share by Region (2021–2026)
Table 19. Global Tacrolimus Sales by Region (K MT), 2027–2032
Table 20. Global Tacrolimus Sales Market Share by Region (2027–2032)
Table 21. Global Tacrolimus Revenue by Region (US$ Million), 2021–2026
Table 22. Global Tacrolimus Revenue Market Share by Region (2021–2026)
Table 23. Global Tacrolimus Revenue by Region (US$ Million), 2027–2032
Table 24. Global Tacrolimus Revenue Market Share by Region (2027–2032)
Table 25. North America Tacrolimus Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Tacrolimus Sales by Country (K MT), 2021–2026
Table 27. North America Tacrolimus Sales by Country (K MT), 2027–2032
Table 28. North America Tacrolimus Revenue by Country (US$ Million), 2021–2026
Table 29. North America Tacrolimus Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Tacrolimus Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Tacrolimus Sales by Country (K MT), 2021–2026
Table 32. Europe Tacrolimus Sales by Country (K MT), 2027–2032
Table 33. Europe Tacrolimus Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Tacrolimus Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Tacrolimus Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Tacrolimus Sales by Region (K MT), 2021–2026
Table 37. Asia Pacific Tacrolimus Sales by Region (K MT), 2027–2032
Table 38. Asia Pacific Tacrolimus Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Tacrolimus Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Tacrolimus Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Tacrolimus Sales by Country (K MT), 2021–2026
Table 42. Latin America Tacrolimus Sales by Country (K MT), 2027–2032
Table 43. Latin America Tacrolimus Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Tacrolimus Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Tacrolimus Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Tacrolimus Sales by Country (K MT), 2021–2026
Table 47. Middle East and Africa Tacrolimus Sales by Country (K MT), 2027–2032
Table 48. Middle East and Africa Tacrolimus Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Tacrolimus Revenue by Country (US$ Million), 2027–2032
Table 50. Global Tacrolimus Sales (K MT) by Type (2021–2026)
Table 51. Global Tacrolimus Sales (K MT) by Type (2027–2032)
Table 52. Global Tacrolimus Sales Market Share by Type (2021–2026)
Table 53. Global Tacrolimus Sales Market Share by Type (2027–2032)
Table 54. Global Tacrolimus Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Tacrolimus Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Tacrolimus Revenue Market Share by Type (2021–2026)
Table 57. Global Tacrolimus Revenue Market Share by Type (2027–2032)
Table 58. Global Tacrolimus Price (USD/MT) by Type (2021–2026)
Table 59. Global Tacrolimus Price (USD/MT) by Type (2027–2032)
Table 60. Global Tacrolimus Sales (K MT) by Application (2021–2026)
Table 61. Global Tacrolimus Sales (K MT) by Application (2027–2032)
Table 62. Global Tacrolimus Sales Market Share by Application (2021–2026)
Table 63. Global Tacrolimus Sales Market Share by Application (2027–2032)
Table 64. Global Tacrolimus Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Tacrolimus Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Tacrolimus Revenue Market Share by Application (2021–2026)
Table 67. Global Tacrolimus Revenue Market Share by Application (2027–2032)
Table 68. Global Tacrolimus Price (USD/MT) by Application (2021–2026)
Table 69. Global Tacrolimus Price (USD/MT) by Application (2027–2032)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 73. GSK Tacrolimus Product
Table 74. GSK Recent Developments/Updates
Table 75. Abbott Company Information
Table 76. Abbott Description and Business Overview
Table 77. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 78. Abbott Tacrolimus Product
Table 79. Abbott Recent Developments/Updates
Table 80. Roche Pharma Company Information
Table 81. Roche Pharma Description and Business Overview
Table 82. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 83. Roche Pharma Tacrolimus Product
Table 84. Roche Pharma Recent Developments/Updates
Table 85. Novartis Company Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 88. Novartis Tacrolimus Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Company Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 93. Mylan Tacrolimus Product
Table 94. Mylan Recent Developments/Updates
Table 95. Squibb Company Information
Table 96. Squibb Description and Business Overview
Table 97. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 98. Squibb Tacrolimus Product
Table 99. Squibb Recent Developments/Updates
Table 100. Astellas Company Information
Table 101. Astellas Description and Business Overview
Table 102. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 103. Astellas Tacrolimus Product
Table 104. Astellas Recent Developments/Updates
Table 105. Aarti Group Company Information
Table 106. Aarti Group Description and Business Overview
Table 107. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 108. Aarti Group Tacrolimus Product
Table 109. Aarti Group Recent Developments/Updates
Table 110. Takeda Company Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 113. Takeda Tacrolimus Product
Table 114. Takeda Recent Developments/Updates
Table 115. Huapont Pharma Company Information
Table 116. Huapont Pharma Description and Business Overview
Table 117. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 118. Huapont Pharma Tacrolimus Product
Table 119. Huapont Pharma Recent Developments/Updates
Table 120. Senju Pharmaceutical Company Information
Table 121. Senju Pharmaceutical Description and Business Overview
Table 122. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 123. Senju Pharmaceutical Tacrolimus Product
Table 124. Senju Pharmaceutical Recent Developments/Updates
Table 125. Guike Pharmaceutical Company Information
Table 126. Guike Pharmaceutical Description and Business Overview
Table 127. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 128. Guike Pharmaceutical Tacrolimus Product
Table 129. Guike Pharmaceutical Recent Developments/Updates
Table 130. Tecoland Company Information
Table 131. Tecoland Description and Business Overview
Table 132. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 133. Tecoland Tacrolimus Product
Table 134. Tecoland Recent Developments/Updates
Table 135. Sandoz Company Information
Table 136. Sandoz Description and Business Overview
Table 137. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 138. Sandoz Tacrolimus Product
Table 139. Sandoz Recent Developments/Updates
Table 140. ScinoPharm Company Information
Table 141. ScinoPharm Description and Business Overview
Table 142. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 143. ScinoPharm Tacrolimus Product
Table 144. ScinoPharm Recent Developments/Updates
Table 145. RPG Life Science Company Information
Table 146. RPG Life Science Description and Business Overview
Table 147. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 148. RPG Life Science Tacrolimus Product
Table 149. RPG Life Science Recent Developments/Updates
Table 150. Suzhou Pharmaceutical Technology Company Information
Table 151. Suzhou Pharmaceutical Technology Description and Business Overview
Table 152. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 153. Suzhou Pharmaceutical Technology Tacrolimus Product
Table 154. Suzhou Pharmaceutical Technology Recent Developments/Updates
Table 155. Accura Pharmaceuticals Company Information
Table 156. Accura Pharmaceuticals Description and Business Overview
Table 157. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 158. Accura Pharmaceuticals Tacrolimus Product
Table 159. Accura Pharmaceuticals Recent Developments/Updates
Table 160. Fujisawa Pharmaceutical Company Information
Table 161. Fujisawa Pharmaceutical Description and Business Overview
Table 162. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 163. Fujisawa Pharmaceutical Tacrolimus Product
Table 164. Fujisawa Pharmaceutical Recent Developments/Updates
Table 165. Sichuan Med-Shine Pharmaceutical Company Information
Table 166. Sichuan Med-Shine Pharmaceutical Description and Business Overview
Table 167. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 168. Sichuan Med-Shine Pharmaceutical Tacrolimus Product
Table 169. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
Table 170. Sinopharm Chuankang Pharmaceutical Company Information
Table 171. Sinopharm Chuankang Pharmaceutical Description and Business Overview
Table 172. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 173. Sinopharm Chuankang Pharmaceutical Tacrolimus Product
Table 174. Sinopharm Chuankang Pharmaceutical Recent Developments/Updates
Table 175. Yamanouchi Pharmaceutical Company Information
Table 176. Yamanouchi Pharmaceutical Description and Business Overview
Table 177. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 178. Yamanouchi Pharmaceutical Tacrolimus Product
Table 179. Yamanouchi Pharmaceutical Recent Developments/Updates
Table 180. Zhongmei Huadong Pharmaceutical Company Information
Table 181. Zhongmei Huadong Pharmaceutical Description and Business Overview
Table 182. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 183. Zhongmei Huadong Pharmaceutical Tacrolimus Product
Table 184. Zhongmei Huadong Pharmaceutical Recent Developments/Updates
Table 185. Hisun Pharmaceutical Company Information
Table 186. Hisun Pharmaceutical Description and Business Overview
Table 187. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
Table 188. Hisun Pharmaceutical Tacrolimus Product
Table 189. Hisun Pharmaceutical Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Tacrolimus Distributors List
Table 193. Tacrolimus Customers List
Table 194. Tacrolimus Market Trends
Table 195. Tacrolimus Market Drivers
Table 196. Tacrolimus Market Challenges
Table 197. Tacrolimus Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tacrolimus
Figure 2. Global Tacrolimus Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Tacrolimus Market Share by Type: 2025 & 2032
Figure 4. Tacrolimus Capsules Product Picture
Figure 5. Tacrolimus Ointment Product Picture
Figure 6. Tacrolimus Injection Product Picture
Figure 7. Global Tacrolimus Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Tacrolimus Market Share by Application: 2025 & 2032
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Other
Figure 12. Global Tacrolimus Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Tacrolimus Market Size (US$ Million), 2021–2032
Figure 14. Global Tacrolimus Sales (K MT), 2021–2032
Figure 15. Global Tacrolimus Average Price (USD/MT), 2021–2032
Figure 16. Tacrolimus Report Years Considered
Figure 17. Tacrolimus Sales Share by Manufacturers in 2025
Figure 18. Global Tacrolimus Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Tacrolimus Players: Market Share by Revenue in Tacrolimus in 2025
Figure 20. Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Tacrolimus Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Tacrolimus Sales Market Share by Country (2021–2032)
Figure 23. North America Tacrolimus Revenue Market Share by Country (2021–2032)
Figure 24. U.S. Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Tacrolimus Sales Market Share by Country (2021–2032)
Figure 27. Europe Tacrolimus Revenue Market Share by Country (2021–2032)
Figure 28. Germany Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Tacrolimus Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Tacrolimus Revenue Market Share by Region (2021–2032)
Figure 35. China Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Taiwan Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Indonesia Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Thailand Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Malaysia Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Philippines Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Latin America Tacrolimus Sales Market Share by Country (2021–2032)
Figure 46. Latin America Tacrolimus Revenue Market Share by Country (2021–2032)
Figure 47. Mexico Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Brazil Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Argentina Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Middle East and Africa Tacrolimus Sales Market Share by Country (2021–2032)
Figure 51. Middle East and Africa Tacrolimus Revenue Market Share by Country (2021–2032)
Figure 52. Turkey Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Saudi Arabia Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. UAE Tacrolimus Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Global Sales Market Share of Tacrolimus by Type (2021–2032)
Figure 56. Global Revenue Market Share of Tacrolimus by Type (2021–2032)
Figure 57. Global Tacrolimus Price (USD/MT) by Type (2021–2032)
Figure 58. Global Sales Market Share of Tacrolimus by Application (2021–2032)
Figure 59. Global Revenue Market Share of Tacrolimus by Application (2021–2032)
Figure 60. Global Tacrolimus Price (USD/MT) by Application (2021–2032)
Figure 61. Tacrolimus Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Related Reports
Global Tacrolimus Market Research Report 2024
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-05
Pages: 115
USD 2900.00
(Single User License)
Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 167
USD 3950.00
(Single User License)
Global Tacrolimus Market Insights, Forecast to 2030
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-22
Pages: 127
USD 4900.00
(Single User License)
Global Tacrolimus Market Research Report 2025
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 108
USD 2900.00
(Single User License)
Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 151
USD 3950.00
(Single User License)
Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 117
USD 4250.00
(Single User License)
Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 158
USD 3950.00
(Single User License)
Global Tacrolimus Market Research Report 2024
The global Tacrolimus market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-05
Pages: 115
USD 2900.00 (Single User License)Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 167
USD 3950.00 (Single User License)Global Tacrolimus Market Insights, Forecast to 2030
The global Tacrolimus market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-22
Pages: 127
USD 4900.00 (Single User License)Global Tacrolimus Market Research Report 2025
The global market for Tacrolimus was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 108
USD 2900.00 (Single User License)Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tacrolimus was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 151
USD 3950.00 (Single User License)Global Tacrolimus Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Tacrolimus market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 117
USD 4250.00 (Single User License)Tacrolimus- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tacrolimus was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 158
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
Why This Report?
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research